Clinical trial
Efficacy and Safety of Moxonidine in Indian Patients
NCT00160277 · Solvay Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00160277 |
|---|---|
| Title | Efficacy and Safety of Moxonidine in Indian Patients |
| Official title | Open Label, Multi-Center, Force-Titration Study to Evaluate the Efficacy and Safety of Moxonidine in Ambulatory Subjects With Essential Hypertension |
| Lead sponsor | Solvay Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | Moxonidine |
| Enrollment | 100 |
| Start date | Jul 1, 2005 |
| First posted | Sep 12, 2005 |
| Last update posted | Jan 30, 2009 |
| Countries | India |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: